Universal Registration Document 2021

Born on October 8, 1959, of American nationality 

First appointment: May 25, 2016

Expiry of term of office: 2024 Annual Ordinary General Shareholders’ Meeting

Number of shares held: 500

Angelic Ventures LP 335 Madison Avenue New York, NY 10017 United States

Biography

Thomas H. Glocer was a corporate lawyer at the Davis Polk & Wardwell law firm before joining Reuters in 1993. He was appointed CEO of Reuters Groupe in 2001 and then from April 2008 to December 2011, CEO of Thomson Reuters Corp.

He is currently Executive Chair of the Board of BlueVoyant LLC and Chair of the Board of Istari Global Ltd, companies specialized in cyber defense, and Executive Chair of the Board of Capitolis Inc., specialized in financial technology. He was also General Partner at Communitas Capital LLC, a venture capital company and member of the Boards of Directors of Morgan Stanley, Merck & Co and Reynen Court

Other offices and positions held within the Groupe

None

Main offices and positions held outside the Groupe

• Founder and Managing Partner: Angelic Ventures LP (United States)
• Executive Chair of the Board: Capitolis, Inc. (United States), BlueVoyant LLC (United States)
• Chair of the Board: Istari Global Ltd (United Kingdom)
• Director: Merck & Co., Inc., listed company (United States), Morgan Stanley, listed company (United States), K2 Intelligence, Inc. (United States), Reynen Court LLC (United States), Atlantic Council (United States)
• General Partner: Communitas Capital LLC (United States)
• Member of the Board of Trustees: Cleveland Clinic (United States)
• Member: President’s Council on International Activities at Yale University (United States), European Business Leaders Council – EBLC – (Finland)
• Member of the Advisory Committee: Columbia Global Center, Paris (United States)
• Member of the International Advisory Group: Linklaters LLP (United Kingdom)

Offices held outside the Groupe in the last five years

Offices listed above